Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rib-X Pharmaceuticals and the Laboratory of Molecular Biology of the Medical Research Council have renewed their research collaboration agreement in the area of ribosome and antibiotic structure and function for an additional year.
Subscribe to our email newsletter
Under the terms of the agreement, Rib-X and the Molecular Biology of the Medical Research Council (MRC) will continue to jointly explore the high resolution crystal structure of the 70S ribosome.
Erin Duffy, vice president of structure-based drug design at Rib-X, said: “Using information discovered about the ribosome during our first year of work with the MRC, Rib-X has been able to advance the iterative intelligent discovery engine that the company developed to design novel antibiotic scaffolds which circumvent the mechanisms employed by resistant bacteria.”